Literature DB >> 111755

Objective assessment of treatment in severe angina.

G D Oakley, K M Fox, H J Dargie, A P Selwyn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 111755      PMCID: PMC1599675          DOI: 10.1136/bmj.1.6177.1540

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  2 in total

1.  Myocardial ischaemia in patients with frequent angina pectoris.

Authors:  A P Selwyn; K Fox; M Eves; D Oakley; H Dargie; J Shillingford
Journal:  Br Med J       Date:  1978-12-09

2.  Transient asymptomatic S-T segment depression during daily activity.

Authors:  S J Schang; C J Pepine
Journal:  Am J Cardiol       Date:  1977-03       Impact factor: 2.778

  2 in total
  10 in total

Review 1.  Silent myocardial ischaemia. Implications for therapy.

Authors:  N G Uren; D P Lipkin
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

Review 2.  Rationale for treatment of silent myocardial ischemia: focus on nifedipine.

Authors:  R W Nesto
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 3.  Silent ischaemia: clinical implications in 1988.

Authors:  K M Fox
Journal:  Br Heart J       Date:  1988-11

Review 4.  Daily life cardiac ischaemia. Should it be treated?

Authors:  B D Bertolet; C J Pepine
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

Review 5.  Adverse reactions to calcium antagonists.

Authors:  J G Lewis
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

6.  Are propranolol and nifedipine synergistic in angina pectoris?

Authors:  B C Campbell
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

Review 7.  Role of calcium antagonists in cardiovascular therapy.

Authors:  H Dargie; E Rowland; D Krikler
Journal:  Br Heart J       Date:  1981-07

8.  Adverse interaction between nifedipine and beta-blockade.

Authors:  L H Opie; D A White
Journal:  Br Med J       Date:  1980-11-29

Review 9.  Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

10.  The combination of nifedipine and propranolol in the management of patients with angina pectoris.

Authors:  A C Tweddel; J M Beattie; R G Murray; I Hutton
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.